| Levocarnitine | hsa00270 | Cysteine and methionine metabolism | 4.56E-02 | 3 | Q99707, P26358, Q9UHY7 | MTR, DNMT1, ENOPH1 | More | |
| Levocarnitine | hsa00534 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin | 3.03E-02 | 1 | O14792 | HS3ST1 | More | |
| Levocarnitine | hsa00591 | Linoleic acid metabolism | 1.65E-02 | 1 | P11712 | CYP2C9 | More | |
| Levocarnitine | hsa00730 | Thiamine metabolism | 4.51E-02 | 1 | Q9Y6K8 | AK5 | More | |
| Levocarnitine | hsa00830 | Retinol metabolism | 3.49E-02 | 1 | P00325 | ADH1B | More | |
| Levocarnitine | hsa00920 | Sulfur metabolism | 1.65E-02 | 1 | Q16762 | TST | More | |
| Levocarnitine | hsa00983 | Drug metabolism - other enzymes | 3.50E-02 | 3 | P04183, P32320, P05164 | TK1, CDA, MPO | More | |
| Levocarnitine | hsa03013 | RNA transport | 4.20E-03 | 13 | O14980, P52298, Q09161, O14893, P37198, Q7Z3B4, P35658, P47813, Q14152, O75822, Q14240, Q9Y6A5, P51114 | XPO1, NCBP2, NCBP1, GEMIN2, NUP62, NUP54, NUP214, EIF1AX, EIF3A, EIF3J, EIF4A2, TACC3, FXR1 | More | |
| Levocarnitine | hsa03022 | Basal transcription factors | 1.91E-02 | 3 | P20226, O00268, Q15544 | TBP, TAF4, TAF11 | More | |
| Levocarnitine | hsa04014 | Ras signaling pathway | 4.65E-02 | 3 | Q15311, P0DP23, P17612 | RALBP1, CALM1, PRKACA | More | |
| Levocarnitine | hsa04064 | NF-kappa B signaling pathway | 1.60E-02 | 8 | P10415, O00463, Q04759, Q9UDY8, Q16548, Q13315, P24522, P09341 | BCL2, TRAF5, PRKCQ, MALT1, BCL2A1, ATM, GADD45A, CXCL1 | More | |
| Levocarnitine | hsa04071 | Sphingolipid signaling pathway | 2.96E-02 | 5 | P21453, Q9H228, Q13362, Q9BX95, P10415 | S1PR1, EDG8, PPP2R5C, SGPP1, BCL2 | More | |
| Levocarnitine | hsa04080 | Neuroactive ligand-receptor interaction | 3.22E-02 | 7 | P08311, Q15722, P21453, Q9H228, O00398, P21730, Q16581 | CTSG, LTB4R, S1PR1, EDG8, P2RY10, C5AR1, C3AR1 | More | |
| Levocarnitine | hsa04114 | Oocyte meiosis | 2.15E-02 | 3 | P0DP23, P17612, Q13362 | CALM1, PRKACA, PPP2R5C | More | |
| Levocarnitine | hsa04115 | p53 signaling pathway | 3.98E-02 | 5 | P24522, Q13315, Q53FA7, O95067, P10415 | GADD45A, ATM, TP53I3, CCNB2, BCL2 | More | |
| Levocarnitine | hsa04122 | Sulfur relay system | 1.65E-02 | 1 | Q16762 | TST | More | |
| Levocarnitine | hsa04142 | Lysosome | 2.98E-02 | 2 | P10619, P49281 | CTSA, SLC11A2 | More | |
| Levocarnitine | hsa04144 | Endocytosis | 4.07E-03 | 5 | Q9H444, O75351, P42566, Q15438, Q14161 | CHMP4B, VPS4B, EPS15, PSCD1, GIT2 | More | |
| Levocarnitine | hsa04210 | Apoptosis | 3.77E-02 | 8 | Q13315, P10415, O76075, P24522, Q16548, P43234, P18848, Q14643 | ATM, BCL2, DFFB, GADD45A, BCL2A1, CTSO, ATF4, ITPR1 | More | |
| Levocarnitine | hsa04213 | Longevity regulating pathway - multiple species | 2.85E-02 | 2 | Q9Y4H2, Q13547 | IRS2, HDAC1 | More | |
| Levocarnitine | hsa04217 | Necroptosis | 4.56E-03 | 4 | P23458, Q9NQC7, Q9H444, O75351 | JAK1, CYLD, CHMP4B, VPS4B | More | |
| Levocarnitine | hsa04261 | Adrenergic signaling in cardiomyocytes | 2.50E-02 | 3 | P17612, Q13362, P0DP23 | PRKACA, PPP2R5C, CALM1 | More | |
| Levocarnitine | hsa04612 | Antigen processing and presentation | 3.21E-02 | 6 | P13765, P48382, P26715, P26717, Q13241, P01732 | HLA-DOB, RFX5, KLRC1, KLRC2, KLRD1, CD8A | More | |
| Levocarnitine | hsa04613 | Neutrophil extracellular trap formation | 1.23E-03 | 5 | P11215, Q13547, P58876, Q16778, O60814 | ITGAM, HDAC1, H2BC5, HIST2H2BE, H2BC12 | More | |
| Levocarnitine | hsa04713 | Circadian entrainment | 4.42E-02 | 2 | P0DP23, P17612 | CALM1, PRKACA | More | |
| Levocarnitine | hsa04720 | Long-term potentiation | 4.42E-02 | 2 | P0DP23, P17612 | CALM1, PRKACA | More | |
| Levocarnitine | hsa04725 | Cholinergic synapse | 4.83E-02 | 4 | P22694, Q14643, P18848, P10415 | PRKACB, ITPR1, ATF4, BCL2 | More | |
| Levocarnitine | hsa04728 | Dopaminergic synapse | 1.55E-02 | 3 | P17612, Q13362, P0DP23 | PRKACA, PPP2R5C, CALM1 | More | |
| Levocarnitine | hsa04740 | Olfactory transduction | 6.71E-03 | 2 | P0DP23, P17612 | CALM1, PRKACA | More | |
| Levocarnitine | hsa04910 | Insulin signaling pathway | 3.62E-02 | 2 | P0DP23, P17612 | CALM1, PRKACA | More | |
| Levocarnitine | hsa04915 | Estrogen signaling pathway | 2.96E-02 | 5 | P14780, P22694, P18848, Q14643, P10415 | MMP9, PRKACB, ATF4, ITPR1, BCL2 | More | |
| Levocarnitine | hsa04916 | Melanogenesis | 2.87E-02 | 2 | P17612, P0DP23 | PRKACA, CALM1 | More | |
| Levocarnitine | hsa04918 | Thyroid hormone synthesis | 3.50E-02 | 3 | P22694, P18848, Q14643 | PRKACB, ATF4, ITPR1 | More | |
| Levocarnitine | hsa04921 | Oxytocin signaling pathway | 1.84E-02 | 3 | P0DP23, P17612, Q96RR4 | CALM1, PRKACA, CAMKK2 | More | |
| Levocarnitine | hsa04924 | Renin secretion | 1.09E-02 | 2 | P17612, P0DP23 | PRKACA, CALM1 | More | |
| Levocarnitine | hsa04927 | Cortisol synthesis and secretion | 8.60E-03 | 3 | Q14643, P18848, P22694 | ITPR1, ATF4, PRKACB | More | |
| Levocarnitine | hsa04928 | Parathyroid hormone synthesis, secretion and action | 2.13E-02 | 5 | Q14643, P22694, P23771, P18848, P10415 | ITPR1, PRKACB, GATA3, ATF4, BCL2 | More | |
| Levocarnitine | hsa04962 | Vasopressin-regulated water reabsorption | 4.51E-02 | 1 | Q9UJW0 | DCTN4 | More | |
| Levocarnitine | hsa04970 | Salivary secretion | 2.20E-02 | 2 | P17612, P0DP23 | PRKACA, CALM1 | More | |
| Levocarnitine | hsa04971 | Gastric acid secretion | 2.87E-02 | 2 | P17612, P0DP23 | PRKACA, CALM1 | More | |
| Levocarnitine | hsa04976 | Bile secretion | 2.20E-02 | 2 | P17612, Q14032 | PRKACA, BAAT | More | |
| Levocarnitine | hsa05031 | Amphetamine addiction | 2.87E-02 | 2 | P0DP23, P17612 | CALM1, PRKACA | More | |
| Levocarnitine | hsa05034 | Alcoholism | 9.58E-05 | 7 | P17612, Q13547, P0DP23, Q96RR4, P58876, Q16778, O60814 | PRKACA, HDAC1, CALM1, CAMKK2, H2BC5, HIST2H2BE, H2BC12 | More | |
| Levocarnitine | hsa05150 | Staphylococcus aureus infection | 8.37E-03 | 5 | P21462, O75015, Q14532, P59665, P59666 | FPR1, FCGR3B, KRT32, DEFA1; DEFA1B, DEFA3 | More | |
| Levocarnitine | hsa05202 | Transcriptional misregulation in cancer | 1.63E-03 | 15 | Q15532, Q13315, P14780, P27930, Q15744, Q16548, P11215, O15550, P05164, P12838, P08246, Q9C0K0, Q13547, P12980, P24522 | SS18, ATM, MMP9, IL1R2, CEBPE, BCL2A1, ITGAM, UTX, MPO, DEFA4, ELA2, BCL11B, HDAC1, LYL1, GADD45A | More | |
| Levocarnitine | hsa05203 | Viral carcinogenesis | 6.44E-03 | 4 | Q13547, P58876, Q16778, O60814 | HDAC1, H2BC5, HIST2H2BE, H2BC12 | More | |
| Levocarnitine | hsa05212 | Pancreatic cancer | 2.87E-02 | 2 | Q15311, P23458 | RALBP1, JAK1 | More | |
| Levocarnitine | hsa05321 | Inflammatory bowel disease | 2.29E-02 | 4 | P13765, Q14765, P23771, Q9HBE5 | HLA-DOB, STAT4, GATA3, IL21R | More | |
| Levocarnitine | hsa05322 | Systemic lupus erythematosus | 1.18E-02 | 3 | P58876, Q16778, O60814 | H2BC5, HIST2H2BE, H2BC12 | More | |
| Levocarnitine | hsa05332 | Graft-versus-host disease | 7.89E-03 | 4 | P13765, P10747, P26715, Q13241 | HLA-DOB, CD28, KLRC1, KLRD1 | More | |
